Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2025

Payables and Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consisted of the following:

	December 31,
(in thousands)	2025		2024
Accrued gross to net revenue liabilities	$	30,272	$	10,112
Accrued sales and marketing expenses	4,598		3,696
Accrued contract manufacturing expenses	2,821		1,402
Accrued medical affairs expenses	2,538		817
Accrued payments due to AstraZeneca	—		12,077
Other	7,348		6,538
Total accrued expenses and other current liabilities	$	47,577	$	34,642